Clinical trial
A Randomized, Open Label, Multicenter Study Comparing the Safety and Efficacy of Once Daily Regimen Containing Epzicom or Truvada Combined With Ritonavir Boosted Atazanavir as Initial Therapy for HIV-1 Infection (ET Study)
NCT00544128 is registered in ClinicalTrials.gov with International Medical Center of Japan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open Label, Multicenter Study Comparing the Safety and Efficacy of Once Daily Regimen Containing Epzicom or Truvada Combined With Ritonavir Boosted Atazanavir as Initial Therapy for HIV-1 Infection (ET Study)
- Lead sponsor
- International Medical Center of Japan
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- February 29, 2012
- Enrollment
- 109 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.